ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chie…
Month: September 2021
ソウル半導体がSunLike自然太陽光スペクトルLED技術の特許・事業権譲渡により事業を拡大
韓国安山市–(BUSINESS WIRE)–ソウル半導体は東芝マテリアルからのSunLike LED技術の特許権および事業権の譲渡が完了したため太陽光スペクトルLED技術の事業拡大を見込んでいる
Nationwide study confirms elderly, female, white populations have higher incidence of GCA
Older, white and female populations are at the highest risk for developing giant cell arteritis, according to research presented at the Women in Ophthalmology Summer Symposium.Karen Qiang, BS, said that previous research had found giant cell arteritis …
Burnout among PAs contributes to medical errors, mental health problems
Burnout, work exhaustion and disengagement are prevalent among physician assistants and may lead to anxiety, depression and medical errors, according to findings published in the Journal of the American Academy of Physician Assistants.Still, 53% of PAs…
Glasses-only wearers wait for doctor recommendation before trying contacts
CooperVision encouraged eye care professionals to educate patients on all relevant vision correction methods, including dual use of contact lenses and glasses, in the company’s latest Consumer Insights Series report.CooperVision commissioned a survey f…
Lineage Announces Appointment of General Counsel
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Global Optic Nerve Injury Drugs Pipeline Report 2021: Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Nerve Injury (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Optic Nerve Injury (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Optic…
Seoul Semiconductor Expands Its Business Through SunLike Natural Sunlight Spectrum LED Technology Patents and Business Rights Transfer
ANSAN, South Korea–(BUSINESS WIRE)– #CircadianRhythmLEDlighting–Seoul Semiconductor acquired all SunLike technology for natural light source jointly developed with Toshiba Materials.